S&P 500   3,225.89 (-3.35%)
DOW   27,960.80 (-3.56%)
QQQ   221.39 (-3.86%)
AAPL   298.18 (-4.75%)
FB   200.72 (-4.50%)
MSFT   170.89 (-4.31%)
GOOGL   1,419.86 (-4.29%)
AMZN   2,009.29 (-4.14%)
CGC   20.30 (-7.22%)
NVDA   273.28 (-7.07%)
BABA   206.16 (-3.02%)
MU   55.01 (-3.47%)
GE   11.86 (-3.18%)
TSLA   833.79 (-7.46%)
AMD   49.12 (-7.81%)
T   38.05 (-1.30%)
ACB   1.55 (-7.19%)
F   7.57 (-4.06%)
NFLX   368.70 (-2.99%)
PRI   126.97 (-4.05%)
BAC   32.73 (-4.74%)
DIS   133.01 (-4.29%)
GILD   72.90 (+4.59%)
S&P 500   3,225.89 (-3.35%)
DOW   27,960.80 (-3.56%)
QQQ   221.39 (-3.86%)
AAPL   298.18 (-4.75%)
FB   200.72 (-4.50%)
MSFT   170.89 (-4.31%)
GOOGL   1,419.86 (-4.29%)
AMZN   2,009.29 (-4.14%)
CGC   20.30 (-7.22%)
NVDA   273.28 (-7.07%)
BABA   206.16 (-3.02%)
MU   55.01 (-3.47%)
GE   11.86 (-3.18%)
TSLA   833.79 (-7.46%)
AMD   49.12 (-7.81%)
T   38.05 (-1.30%)
ACB   1.55 (-7.19%)
F   7.57 (-4.06%)
NFLX   368.70 (-2.99%)
PRI   126.97 (-4.05%)
BAC   32.73 (-4.74%)
DIS   133.01 (-4.29%)
GILD   72.90 (+4.59%)
S&P 500   3,225.89 (-3.35%)
DOW   27,960.80 (-3.56%)
QQQ   221.39 (-3.86%)
AAPL   298.18 (-4.75%)
FB   200.72 (-4.50%)
MSFT   170.89 (-4.31%)
GOOGL   1,419.86 (-4.29%)
AMZN   2,009.29 (-4.14%)
CGC   20.30 (-7.22%)
NVDA   273.28 (-7.07%)
BABA   206.16 (-3.02%)
MU   55.01 (-3.47%)
GE   11.86 (-3.18%)
TSLA   833.79 (-7.46%)
AMD   49.12 (-7.81%)
T   38.05 (-1.30%)
ACB   1.55 (-7.19%)
F   7.57 (-4.06%)
NFLX   368.70 (-2.99%)
PRI   126.97 (-4.05%)
BAC   32.73 (-4.74%)
DIS   133.01 (-4.29%)
GILD   72.90 (+4.59%)
S&P 500   3,225.89 (-3.35%)
DOW   27,960.80 (-3.56%)
QQQ   221.39 (-3.86%)
AAPL   298.18 (-4.75%)
FB   200.72 (-4.50%)
MSFT   170.89 (-4.31%)
GOOGL   1,419.86 (-4.29%)
AMZN   2,009.29 (-4.14%)
CGC   20.30 (-7.22%)
NVDA   273.28 (-7.07%)
BABA   206.16 (-3.02%)
MU   55.01 (-3.47%)
GE   11.86 (-3.18%)
TSLA   833.79 (-7.46%)
AMD   49.12 (-7.81%)
T   38.05 (-1.30%)
ACB   1.55 (-7.19%)
F   7.57 (-4.06%)
NFLX   368.70 (-2.99%)
PRI   126.97 (-4.05%)
BAC   32.73 (-4.74%)
DIS   133.01 (-4.29%)
GILD   72.90 (+4.59%)
Log in

NASDAQ:AXLA - Axcella Health Stock Price, Forecast & News

$4.60
-0.35 (-7.07 %)
(As of 02/24/2020 04:00 PM ET)
Today's Range
$4.60
Now: $4.60
$5.00
50-Day Range
$3.92
MA: $4.82
$5.24
52-Week Range
$2.76
Now: $4.60
$15.99
Volume20,653 shs
Average Volume45,771 shs
Market Capitalization$106.32 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
There is no company description available for Axcella Health Inc.

Industry, Sector and Symbol

Industry Biological products, except diagnostic
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:AXLA
CUSIPN/A
CIKN/A
Phone857-320-2200

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Net Income$-36,070,000.00

Miscellaneous

EmployeesN/A
Market Cap$106.32 million
Next Earnings Date2/25/2020 (Estimated)
OptionableNot Optionable

Receive AXLA News and Ratings via Email

Sign-up to receive the latest news and ratings for AXLA and its competitors with MarketBeat's FREE daily newsletter.


Axcella Health (NASDAQ:AXLA) Frequently Asked Questions

What is Axcella Health's stock symbol?

Axcella Health trades on the NASDAQ under the ticker symbol "AXLA."

How were Axcella Health's earnings last quarter?

Axcella Health Inc (NASDAQ:AXLA) released its quarterly earnings results on Tuesday, November, 12th. The company reported ($0.75) earnings per share for the quarter, missing analysts' consensus estimates of ($0.71) by $0.04. View Axcella Health's Earnings History.

When is Axcella Health's next earnings date?

Axcella Health is scheduled to release their next quarterly earnings announcement on Tuesday, February 25th 2020. View Earnings Estimates for Axcella Health.

What price target have analysts set for AXLA?

4 brokerages have issued 12 month price targets for Axcella Health's stock. Their forecasts range from $20.00 to $25.00. On average, they anticipate Axcella Health's stock price to reach $22.00 in the next twelve months. This suggests a possible upside of 378.3% from the stock's current price. View Analyst Price Targets for Axcella Health.

What is the consensus analysts' recommendation for Axcella Health?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Axcella Health in the last year. There are currently 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Axcella Health.

Has Axcella Health been receiving favorable news coverage?

Press coverage about AXLA stock has trended somewhat positive this week, InfoTrie Sentiment reports. The research group identifies positive and negative news coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Axcella Health earned a media sentiment score of 2.0 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an effect on the stock's share price in the next several days. View News Stories for Axcella Health.

Are investors shorting Axcella Health?

Axcella Health saw a drop in short interest in January. As of January 31st, there was short interest totalling 108,000 shares, a drop of 12.1% from the January 15th total of 122,800 shares. Based on an average daily volume of 66,300 shares, the short-interest ratio is presently 1.6 days. Currently, 1.3% of the shares of the company are short sold. View Axcella Health's Current Options Chain.

Who are some of Axcella Health's key competitors?

What other stocks do shareholders of Axcella Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Axcella Health investors own include Triton International (TRTN), Main Street Capital (MAIN), Agile Therapeutics (AGRX), vTv Therapeutics (VTVT), Vaxart (VXRT), Armata Pharmaceuticals (ARMP), Aduro BioTech (ADRO), Amarin (AMRN), Aytu Bioscience (AYTU) and Exelixis (EXEL).

When did Axcella Health IPO?

(AXLA) raised $76 million in an IPO on Thursday, May 9th 2019. The company issued 3,600,000 shares at $20.00-$22.00 per share. Goldman Sachs, J.P. Morgan and SVB Leerink served as the underwriters for the IPO.

Who are Axcella Health's major shareholders?

Axcella Health's stock is owned by a number of of institutional and retail investors. Top institutional investors include FMR LLC (13.90%), State Street Corp (0.25%), Geode Capital Management LLC (0.17%), Bank of New York Mellon Corp (0.09%), UBS Group AG (0.08%) and Charles Schwab Investment Management Inc. (0.07%). Company insiders that own Axcella Health stock include Catherine A Sohn, D Clay Bretches, David R Epstein, Laurent Chardonnet and Ventures Fund Iv LP Flagship. View Institutional Ownership Trends for Axcella Health.

Which major investors are selling Axcella Health stock?

AXLA stock was sold by a variety of institutional investors in the last quarter, including FMR LLC. View Insider Buying and Selling for Axcella Health.

Which major investors are buying Axcella Health stock?

AXLA stock was bought by a variety of institutional investors in the last quarter, including State Street Corp, Geode Capital Management LLC, Bank of New York Mellon Corp, UBS Group AG, Charles Schwab Investment Management Inc., Jacobs Levy Equity Management Inc. and Barclays PLC. Company insiders that have bought Axcella Health stock in the last two years include Catherine A Sohn, D Clay Bretches, David R Epstein, Laurent Chardonnet and Ventures Fund Iv LP Flagship. View Insider Buying and Selling for Axcella Health.

How do I buy shares of Axcella Health?

Shares of AXLA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Axcella Health's stock price today?

One share of AXLA stock can currently be purchased for approximately $4.60.

How big of a company is Axcella Health?

Axcella Health has a market capitalization of $106.32 million. View Additional Information About Axcella Health.

What is Axcella Health's official website?

The official website for Axcella Health is http://www.axcellahealth.com/.

How can I contact Axcella Health?

Axcella Health's mailing address is 840 MEMORIAL DRIVE, CAMBRIDGE MA, 02139. The company can be reached via phone at 857-320-2200.


MarketBeat Community Rating for Axcella Health (NASDAQ AXLA)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  34 (Vote Outperform)
Underperform Votes:  39 (Vote Underperform)
Total Votes:  73
MarketBeat's community ratings are surveys of what our community members think about Axcella Health and other stocks. Vote "Outperform" if you believe AXLA will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AXLA will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/24/2020 by MarketBeat.com Staff

Featured Article: What is a back-end load?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel